DS Laboratories (the flagship brand of DS Healthcare) makes the well known Revita and Spectal DNC line of hair loss products. Men and women can both use these products. Update 2019: Ownership change in the Miami-based DS Labs. The CEO remains Dr. Fernando Tamez.
Revita from DS Laboratories
The most famous product from DS Labs is the Revita shampoo for hair growth stimulation. It contains several dihydrotestosterone blockers as well as ketoconazole, caffeine, and biotin. Make sure to also read my posts on natural DHT blockers and Nizoral shampoo.
According to DS Healthcare, Revita combines antioxidant and anti-androgenic properties. It also contains powerful hydrating molecules, hair-growth stimulants, and amino acids. Amazon reviews currently give the product an average rating of 4 out of 5 stars. The company also sells Revita conditioner.
Spectral DNC Hair Loss Products
DS Laboratories also makes the well known Spectral.DNC-N topical hair loss treatment. It contains the company’s proprietary Nanoxidil® alternative to Minoxidil (Rogaine). The product makes use of nanosome delivery technology. I have not read of any users claiming major side effects. However, please do your own research from reading many customer reviews.
According to the official product description:
The compounds used in Spectral.DNC-N have in clinical studies shown to open ion channels within cells; suppress dihydrotestosterone; prevent perifollicular fibrosis; provide antioxidant effects; prolong the anagen phase of hair follicles; increase expression of VEGF; suppress protein-kinase-C isozymes; and block chronic inflammation.
Other well known products sold by DS Laboratories include: the Spectral.CSF hair revitalizing treatment for women; and the Dandrene brand dandruff shampoo.
DS Healthcare Patent
Last week, DS Healthcare Group filed its second patent (first one was filed in October 2013) related to a new proprietary topical hair loss treatment. From the news release regarding this development:
“This new patent addresses the composition and methods of a new compound described as a calcium-activated potassium channel opening agent for topical treatment of hair loss.”
According to the company’s CEO Daniel Khesin (Edit: now former), this patent-pending molecule will produce better hair regrowth than topical minoxidil.